Is Yumanity Therapeutics, Inc. (YMTX) A Good Stock To Buy?
In this article we will analyze whether Yumanity Therapeutics, Inc.
No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
---|---|---|---|---|---|
1. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% | |
2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
5. | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.75 | 40,000 | Director | 40,000 | 2018-10-26 | Filing | |
$5.00 | 2,000,000 | Large Shareholder, Director | 5,554,610 | 2017-12-18 | Filing | |
$5.00 | 2,000,000 | Large Shareholder | 5,554,610 | 2017-12-18 | Filing | |
$5.00 | 40,000 | Officer, Director | 50,218 | 2017-12-18 | Filing | |
$5.00 | 4,000 | Director | 102,411 | 2017-12-18 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.19 | 1,806 | Officer | 10,859 | 2022-06-03 | Filing | |
$1.19 | 2,923 | Officer | 17,077 | 2022-06-03 | Filing | |
$1.19 | 2,887 | Officer | 17,113 | 2022-06-03 | Filing | |
$1.19 | 10,206 | Officer, Director | 105,502 | 2022-06-03 | Filing | |
$1.85 | 10,715 | Officer, Director | 115,708 | 2022-03-28 | Filing |
No. | Name | Shares | Value (x$1000) | % Port |
---|---|---|---|---|
1. | 0 | $0 | 0% | |
2. | 0 | $0 | 0% | |
3. | 0 | $0 | 0% | |
4. | 0 | $0 | 0% | |
5. | 0 | $0 | 0% |